The increasing scale of morbidity and the intensification of diagnostics (including the widespread use of mpMRI before biopsy and the increasing use of PET-CT with PSMA radiolabectors) create significant challenges for physicians. The large number of imaging studies and the need for their rapid and precise interpretation make the support of advanced tools indispensable.
Auto-segmentation and image analysis
Tools such as Prostate.Carcinoma.AI enable fully automatic segmentation of the prostate and its zones element by element, and then detect suspicious changes. This dramatically reduces the time of the initial assessment, reduces the risk of errors and ensures consistency and objectivity of the results.
Reduction of unnecessary biopsies
Highly specific and sensitive AI algorithms increase negative predictive value, allowing clinicians to reduce the number of invasive procedures. Fewer unnecessary biopsies mean a lower risk of complications, less burden on the patient and savings for the medical facility.
PI-RADS classification and support in PET/CT
AI algorithms help classify suspicious foci based on PI-RADS 2.1, unifying MRI interpretation. Similar innovations are emerging in the area of PET/CT, allowing a precise assessment of the total tumor burden and a better qualification for targeted therapies.
Personalization of treatment and therapy planning
AI can predict response to treatment, which has been highlighted in the analytical work of various research teams. This allows doctors to select the most effective therapeutic path faster, avoiding costly, ineffective methods.
Artificial intelligence has become a real support for the doctor in the diagnosis and treatment of patients. Thanks to advanced algorithms, AI reduces the time of interpretation of studies, increases safety, improves the accuracy of detection of cancer lesions and personalization of therapy.
Support DoctorMe by participating in the study of the needs of doctors in access to AI in medical practice!
We present a catalog of certified AI products for this clinical area. If you are interested in a specific solution, please contact us — we will help you organize a demo workshop or an online presentation with the manufacturer.
It is an advanced AI software that supports image analysis MRI of the prostate. It automates the segmentation of the prostate and suspicious changes according to PI-RADS 2.1 guidelines, facilitating the work of radiologists and accelerating the diagnosis of prostate cancer. The software acts as a plug-in to the mint Lesion™ system and offers precise, three-dimensional segmentation and automatic PSA density calculations.
Key Features:
Contact us for detailed information about this product and the possibilities to implement it in your practice.
Schedule a FREE Consultation
TULSA-PRO® is an effective, minimally invasive prostate ablation system using directional ultrasound under the control of MRI. The procedure without radiation or incisions, precisely treats tumors and prostatic hyperplasia, minimizing the risk of complications and maintaining sexual function and control over urination. Performed in one-day mode, offers a quick recovery and an individually tailored treatment plan.
Key Features:
Contact us for detailed information about this product and the possibilities to implement it in your practice.
Schedule a FREE Consultation
Butterfly iQ+ is a portable, holistic ultrasound scanner that allows imaging of the entire body, including the bladder and prostate. With Pulse Wave Doppler technology and function AI-Enabled Auto B-Line Counter, provides precise measurements in real time. It is durable, waterproof and offers quick calculation of bladder volume and evaluation of urological structures. Additional AI applications extend the functionality of the device, supporting comprehensive diagnostics.
Key Features:
Contact us for detailed information about this product and the possibilities to implement it in your practice.
Schedule a FREE Consultation
It is a processing tool MRI images, which improves imaging quality and reduces scanning time by up to 50%. Thanks to advanced AI algorithms, it allows to obtain clearer and more accurate images, which supports diagnostics in oncological urology, especially in the detection of prostate cancer. It increases the throughput of the MRI laboratory and facilitates faster diagnosis.
Key Features:
Contact us for detailed information about this product and the possibilities to implement it in your practice.
Schedule a FREE Consultation
mdprostate is an AI tool for automatic image analysis MRI of the prostate, supporting radiologists and urologists in the diagnosis of prostate cancer. Classifies changes according to PI-RADS 2.1, generates reports in less than 3 minutes, visualizes changes on schematic sector maps and allows comparisons with previous studies.
Key Features:
Contact us for detailed information about this product and the possibilities to implement it in your practice.
Schedule a FREE Consultation
It's an AI-powered SaaS solution to support diagnostics MRI of prostate cancer. Increases biopsy sensitivity from 92% to 97% and reduces lesion identification time by 27%. Generates three-dimensional images of the prostate with the ability to export to fusion biopsy systems. The tool improves the efficiency of the work of radiologists, supporting both experts and less experienced specialists.
Key Features:
Contact us for detailed information about this product and the possibilities to implement it in your practice.
Schedule a FREE Consultation
Pi™ is an AI software that helps radiologists detect cancer changes in images MRI of the prostate. The system offers automatic classification of lesions with risk assessment, facilitates the identification of areas for biopsy and provides segmentations comparable to expert results. In clinical studies, Pi™ has been shown to reduce the proportion of undetected significant prostate cancers from 12% to 6%, as well as reduce the number of unnecessary biopsies from 55% to 43%.
Key Features:
Contact us for detailed information about this product and the possibilities to implement it in your practice.
Schedule a FREE Consultation
Paige Prostate Suite is an AI tool to support pathologists in digital-based prostate cancer diagnosis Biopsy images. It automatically detects and evaluates areas suspected of cancer, providing precise information and increasing diagnostic efficiency.
Key Features:
Contact us for detailed information about this product and the possibilities to implement it in your practice.
Schedule a FREE Consultation
The Clarius HD3 with Bladder AI is a portable ultrasound scanner with AI capability to automatic bladder volume measurements. The system is wireless, easy to use and provides high-quality real-time imaging.
Key Features:
Contact us for detailed information about this product and the possibilities to implement it in your practice.
Schedule a FREE ConsultationConsistent, repeatable and objective results reduce the risk of human error and differences in interpretation between specialists.
Fewer invasive procedures, faster analysis and a reduction in unnecessary imaging tests are real savings for hospitals and clinics.
Faster diagnosis, greater accuracy of decisions and better communication of results translate into a higher level of trust and comfort for patients.
Standardization and certainty of diagnosis
Cost optimization and increased efficiency
Improving Patient Satisfaction
With the growing number of clinically validated AI solutions, healthcare is moving towards a model of personalized care and their integration into the ecosystem (PACS, RIS, EHR) is becoming easier.
DoctorMe supports medics like you by facilitating access to AI solutions. We want innovation to be easily accessible to doctors and become a real help. Let's talk about your needs!
We present AI solutions in development that can revolutionize diagnostics and treatment. It is worth following them to keep abreast of new technologies.
DeepPSMA is an AI image analysis tool PSMA-PET/CT, which automatically and precisely quantifies the tumor burden throughout the body. It helps radiologists obtain detailed information about the characteristics of the tumor, improving the efficiency and relevance of clinical decisions.
selectPSMA helps predict treatment outcomes with PSMA therapies such as Pluvicto. It helps to identify patients who will not benefit from treatment, avoiding ineffective therapies and their side effects.
Key Features:
Contact us for detailed information about this product and the possibilities to implement it in your practice.
Schedule a FREE ConsultationAI enables more accurate and faster image evaluation and more personalized qualification for therapy.
Reducing the number of unnecessary biopsies, reducing test interpretation time, and improving diagnostic certainty are tangible benefits not only for doctors and patients, but for the entire healthcare system.
The further development of AI and easier access to innovative tools (supported by platforms such as DoctorMe) contribute to the continuous improvement of standards of medical care and better treatment outcomes for patients with prostate cancer.
Let's stay in touch so you can:
